Evidence map›Paper›PMID 11252722›Full record

ArticleEMBO reports2001

The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.

P Delerive, D Monté, G Dubois, F Trottein, J Fruchart-Najib, J Mariani, J C Fruchart, B Staels

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 1 synthesis or guideline pooled it, 290 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Epigenetic Switches in Retinal Homeostasis and Target for Drug Development.International journal of molecular sciences · 2024
    Review

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

P DeleriveINSERM U325, Département d'Athérosclérose, Institut Pasteur de Lille, France.
D Monté
G Dubois
F Trottein
J Fruchart-Najib
J Mariani
J C Fruchart
B Staels
Inserm · FRInstitut Pasteur de Lille · FRInstitut de Biologie de Lille · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoid-related orphan receptor alpha (ROR alpha) (NR1F1) is a member of the nuclear receptor superfamily whose biological functions are largely unknown. Since staggerer mice, which carry a deletion in the ROR alpha gene, suffer from immune abnormalities, we generated an adenovirus encoding ROR alpha1 to investigate its potential role in control of the inflammatory response. We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells. ROR alpha1 negatively interferes with the NF-kappaB signalling pathway by reducing p65 translocation as demonstrated by western blotting, immunostaining and electrophoretic mobility shift assays. This action of ROR alpha1 on NF-kappaB is associated with the induction of IkappaB alpha, the major inhibitory protein of the NF-kappaB signalling pathway, whose expression was found to be transcriptionally upregulated by ROR alpha1 via a ROR response element in the IkappaB alpha promoter. Taken together, these data identify ROR alpha1 as a potential target in the treatment of chronic inflammatory diseases, including atherosclerosis and rheumatoid arthritis.

Indexed as

Calcium-Binding ProteinsI-kappa B ProteinsAdenoviridaeBlotting, WesternCell NucleusCells, CulturedCyclooxygenase 2DNA-Binding ProteinsDNA, ComplementaryHumansImmunoblottingImmunohistochemistryInflammationInterleukin-6Interleukin-8IsoenzymesCalcium-Binding ProteinsCyclooxygenase 2DNA-Binding ProteinsDNA, ComplementaryI-kappa B ProteinsInterleukin-6Interleukin-8IsoenzymesMembrane GlycoproteinsMembrane ProteinsNerve Tissue ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mouseNuclear Receptor Subfamily 1, Group F, Member 1Prostaglandin-Endoperoxide SynthasesPTGS2 protein, humanReceptors, Cytoplasmic and NuclearRNARORA protein, humanRora protein, mouseSynaptotagmin ISynaptotagminsTrans-ActivatorsTumor Necrosis Factor-alpha

Identifiers

PMID11252722
PMCPMC1083804
OpenAlexW2068820723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.